Deficiency of cytosolic arylamine N-acetylation in the domestic cat and wild felids caused by the presence of a single NAT1-like gene

Pharmacogenetics

Volumn 8, Issue 2, 1998, Pages 169-179

  Trepanier, Lauren A ^a,d   Cribb, Alastair E ^b   Spielberg, Stephen P ^c   Ray, Kunal ^a  

^a Animal Health Diagnostic Center   (United States)

^b UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Arylamine acetyltransferase; Biotransformation; Cat; Deficiency

Indexed keywords

4 AMINOBENZOIC ACID; ARYLAMINE ACETYLTRANSFERASE; ISOENZYME; SULFADIMIDINE;

ACYLATION; AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BLADDER; CAT; COLON; CONTROLLED STUDY; DRUG TRANSFORMATION; ENZYME DEFICIENCY; ENZYME SPECIFICITY; IMMUNOHISTOCHEMISTRY; LIVER METABOLISM; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; STRAIN DIFFERENCE; WILDLIFE;

EID: 0031960330     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199804000-00009     Document Type: Article

References (53)

1. Andres HH, Weber WW. N-acetylation pharmacogenetics: Michaelis - Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo. Drug Metab Disp 1986; 14:382-385.
2. Andres HH, Kolb HJ, Schreiber RJ, Weiss L. Characterization of the active site, substrate specificity, and kinetic properties of acetyl-CoA: arylamine N-acetyltransferase from pigeon liver. Biochim Biophys Acta 1983; 746:193-201.
3. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA et al., editors. Short protocols in molecular biology. 2nd ed. New York: John Wiley & Sons: 1992.
4. Aymes SJG, Roberts PM, Scott PP, Suri S. Post-natal changes in red cell, plasma and liver folate concentrations of the cat, rat, rabbit, and dog. J Physiol 1973; 232:23P-24P.
5. Blum M, Grant DM, Demierre A, Meyer UA. N-acetylation pharmacogenetics: a gene deletion causes absence of arylamine N-acetyltransferase in liver of slow acetylator rabbits. Proc Natl Acad Sci USA 1989; 86:9554-9557.
6. Blum M, Grant DM, McBride W, Heim M, Meyer UA. Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol 1990; 9:193-203.
7. Blum M, Demierre A, Grant DM, Heim M, Meyer UA. Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc Natl Acad Sci USA 1991; 88:5237-5241.
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
9. Bridges JW, Williams RT. Species differences in the acetylation of sulphanilamide. Biochem J 1963; 87:19P.
10. Bridges JW, Kirby MR, Walker SR, Williams RT. Species differences in the metabolism of sulphadimethoxine. Biodiem J 1968; 109:851-856.
11. Caldwell J. Comparative aspects of drug conjugation in laboratory animals, exotic species, and man. In: van Miert A, Bogaert MG, Debackere M, editors. Comparative veterinary pharmacology, toxicology, and therapy. Norwell. MA: MTP Press Ltd; 1985. pp. 285-294.
12. Chung JG, Wang HH, Tsou MF, Hsieh SE, Lo HH, Yen YS et al. Evidence for arylamine N-acetyltransferase activity in the bacterium Helicobarter pylori. Toxicol Lett 1997; 91:63-71.
13. Cornish-Bowden A. Fundamentals of enzyme kinetics. London: Portland Press; 1995.
14. Cribb AE, Grant DM, Miller M, Spielberg SP. Expression of monomorphic arylamine N-acetyltransferase (NAT1) in human leukocytes. J Pharmacol Exp Ther 1991; 259:1241-1246.
15. 64 in the catalytic function of human N-acetyltransferases NAT1 and NAT2 by site-directed mutagenesis. Biochem J 1997; 323:207-215.
16. Doll MA, Hein DW. Cloning, sequencing and expression of NAT1 and NAT2 encoding genes from rapid and slow acetylator inbred rats. Pharmacogenetics 1995; 5, 247-251.
17. Dupret J-M, Grant DM. Site-directed mutagenesis of recombinant human arylamine N-acetyltransferase expressed in Escherichia coli. J Biol Chem 1992; 267:7381-7385.
18. Dupret J-M, Goodfellow GH, Janezic SA, Grant DM. Structure-function studies of human arylamine N-acetyltransferases NAT1 and NAT2. J Biol Chem 1994; 269:26830-26835.
19. Glinkuson T, Benjamin T, Grantham PH, Weisburger EK, Roller PP. Enzymic N-acetylation of 2,4-toluenediamine by liver cytosols from various species. Xenobiotica 1975; 5:475-483.
20. Goodfellow GH, Grant DM. Structure-function studies of human acetyltransferases NAT1 and NAT2: identification of amino acids imparting arylamine substrate specificity. Proceedings of the 10th international symposium on microsomes and drug oxidations; Toronto. Canada; 1994. p. 440.
21. Grant DM, Blum M, Beer M, Meyer UA. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparision of liver isozymes and expressed products of two cloned genes. Mol Pharmacol 1991; 39:184-191.
22. Gregus Z, Watkins JB, Thompson TN, Harvey MJ, Rozman K, Klaasen CD. Hepatic phase I and phase II biotransformation in quail and trout: comparison to other species commonly used in toxicity testing. Toxicol Applied Pharmacol 1983; 67:430-441.
23. Hein DW, Kirlin WG, Ferguson RJ, Thompson LK, Ogolla F. Identification and inheritance of inbred hamster N-acetyltransferase isozymes in peripheral blood. J Pharmacol Exp Ther 1986; 239:823-828.
24. Hein DW, Rustan TD, Bucher KD, Martin WJ, Furman EJ. Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver. Drug Metab Disp 1991; 19:933-937.
25. Ho CC, Lin TH, Lai YS, Chung JG, Levy GN, Weber WW. Kinetics of acetyl coenzyme A: arylamine N-acetyltransferase from rapid and slow acetylator frog tissues. Drug Metab Disp 1996; 24:137-141.
26. Hughes NC, Grant DM. Cloning and expression of new mutant forms of human acetyltransferase NAT1 with defective function. Proceedings of the 10th international symposium on microsomes and drug oxidations, Toronto, Canada; 1994. p. 278.
27. Ilett KF, Reeves PT, Minchin RF, Kinnear BF, Watson HF, Kadlubar FF. Distribution of acetyltransferase activities in the intestines of rapid and slow acetylator rabbits. Carcinogenesis 1991; 12:1465-1469.
28. Kato R, Yamazoe Y. Molecular mechanisms of polymorphism in acetylating enzymes for arylamines and N-hydroxyarylamines in hamster liver. Drug Metab Rev 1995; 27:241-256.
29. Marshall EK. Acetylation of sulfonamides in the dog. J Biol Chem 1954; 211:499-503.
30. Martell KJ, Levy GN, Weber WW. Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products. Mol Pharmacol 1992; 42:265-272.
31. Mattano SS, Land S, King CM, Weber WW. Purification and biochemical characterization of hepatic arylamine N-acetyltransferase from rapid and slow acetylator mice: identity with arylhydroxamic acid N, O-acetyltransferase and N-hyroxylamine O-acetyltransferase. Mol Pharmacol 1989; 35:599-609.
32. McPartlin J, Halligan A, Scott JM, Darling M, Weir DG. Accelerated folate breakdown in pregnancy. Lancet 1993; 341:148-149.
33. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nuc Acids Res 1988; 16:1215.
34. Minchin RF. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by the recombinant human arylamine N-acetyltransferase and U937 cells. Biochem J 1995; 307:1-3.
35. Noli C, Koeman JP, Willemse T. A retrospective evaluation of adverse reactions to trimethoprim-sulfonamide combinations in dogs and cats. Vet Quarterly 1995; 17:123-128.
36. Nouws JFM, Vree TB, Breukink HJ, van Miert ASJPAM, Grondel J. Pharmacokinetics, hydroxylation, and acetylation of sulphadimidine in mammals, birds, fish, reptiles, and molluscs. In: van Miert A, Bogaert MG, Debackere M, editors. Comparative veterinary pharmacology, toxicology, and therapy. Norwell MA: MTP Press Ltd; 1985. pp. 301-318.
37. Ohsako S, Oeguchi T. Cloning and expression of cDNA's for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. J Biol Chem 1990; 265:4630-4634.
38. Peters JH, Gordon GR, Biggs JT, Levy L. The disposition of dapsone and monoacetyldapsone in the dog. Proc Soc Exp Biol Med 1975; 148:251-255.
39. Plumb DC. Veterinary drug handbook. Ames, IA: Iowa State University Press; 1995.
40. Poirier LA, Miller JA, Miller EC. The N- and ring-hydroxylation of 2-acetylaminofluorene and the failure to detect N-acetylation of 2-aminofluorene in the dog. Cancer Res 1963; 23:790-800.
41. Reeves PT, Kinnear BF, Minchin RF, Ilett K. Immunological evidence for N-acetyltransferase isozymes in the rabbit. Mol Pharmacol 1991; 39:42-48.
42. Rougraff PM, Paxton R. Purification and partial characterization of chicken liver acetyl coenzyme A arylamine N-acetyltransferase. Comp Biochem Physiol 1987; 868:601-606.
43. Sasaki Y, Ohsako S, Deguchi T. Molecular and genetic analyses of arylamine N-acetyltransferase polymorphism of rabbit liver J Biol Chem 1991; 266:13243-13259.
44. Scott DW, Miller WH, Griffin CE. Muller & Kirk's small animal dermatology. 5th ed. Philadelphia: WB Saunders Co; 1995. p. 235.
45. Sonawane BR. Perinatal development of N-acetyltransferase in hepatic and extrahepatic tissues in guinea pigs. Ped Pharmacol 1982; 2:223-229.
46. Stanley LA, Corneos E, Cuff R, Hickman D, Ward A, Sim E. Immunochemical detection of arylamine N-acetyltransferase in normal and neoplastic bladder. J Histochem Cytochem 1996; 44:1059-1067.
47. Trepanier LA, Ray K, Winand N, Spielberg SP, Cribb AE. Cytosolic arylamine N-acetyltransferase deficiency in the dog and other canids due to an absence of NAT genes. Biochem Pharmacol 1997; 54:73-80.
48. Vree TB, Nouws JFM, Hekster YA. Comparative pharmacokinetic studies of sulphonamides. In: van Miert A, Bogaert MG, Debackere M, editors. Comparative veterinary pharmacology, toxicology, and therapy. Norwell, MA: MTP Press Ltd; 1985. pp. 173-185.
49. Ward A, Summers MJ, Sim E. Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E. coli and characterization of its potential role in folate metabolism. Biochem Pharmacol 1995; 49:1759-1767.
50. 69 residue in the catalytic mechanism of N-hydroxyarylamine O-acetyltransfease of Salmonella typhimurium. J Biol Chem 1992; 267:8429-8436.
51. Weber WW. The acetylator genes and drug response. New York: Oxford University Press; 1987.
52. Weber WW, Cohen SN. N-acetylation of drugs: isolation and properties of N-acetyltransferase from rabbit liver. Mol Pharmacol 1967; 3:266-273.
53. Williams RT. Comparative patterns of drug metabolism. Fed Proc 1967; 26:1029-1039.